An international study led by a researcher from IDIBAPS-Hospital Clínic Barcelona demonstrates the first significant improvement in the treatment of a subtype of liver cancer in twenty years
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. Inv1